Matches in Wikidata for { <http://www.wikidata.org/entity/Q90830377> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q90830377 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q90830377 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90830377 description "scientific article published on 02 April 2020" @default.
- Q90830377 description "wetenschappelijk artikel" @default.
- Q90830377 description "наукова стаття, опублікована 2 квітня 2020" @default.
- Q90830377 name "Lignin-graft-PLGA drug-delivery system improves efficacy of MEK1/2 inhibitor in triple-negative breast cancer cell line" @default.
- Q90830377 name "Lignin-graft-PLGA drug-delivery system improves efficacy of MEK1/2 inhibitor in triple-negative breast cancer cell line" @default.
- Q90830377 type Item @default.
- Q90830377 label "Lignin-graft-PLGA drug-delivery system improves efficacy of MEK1/2 inhibitor in triple-negative breast cancer cell line" @default.
- Q90830377 label "Lignin-graft-PLGA drug-delivery system improves efficacy of MEK1/2 inhibitor in triple-negative breast cancer cell line" @default.
- Q90830377 prefLabel "Lignin-graft-PLGA drug-delivery system improves efficacy of MEK1/2 inhibitor in triple-negative breast cancer cell line" @default.
- Q90830377 prefLabel "Lignin-graft-PLGA drug-delivery system improves efficacy of MEK1/2 inhibitor in triple-negative breast cancer cell line" @default.
- Q90830377 P1433 Q90830377-0D6244C6-93A9-408C-8534-EEBF38FBE7E9 @default.
- Q90830377 P1476 Q90830377-F2C0AF6E-480D-4F58-B66A-431B8391E893 @default.
- Q90830377 P2093 Q90830377-1283E454-0257-41BB-9107-08CB37669D18 @default.
- Q90830377 P2093 Q90830377-4BE3A045-17BC-4F46-9041-ED37C1005087 @default.
- Q90830377 P2093 Q90830377-7D75D594-3D9A-4456-A8A8-01591488D885 @default.
- Q90830377 P2093 Q90830377-985848F1-FB20-4AFF-9C60-4F52D682663B @default.
- Q90830377 P2093 Q90830377-C8BF8886-9C8D-400D-830C-4258214A1FE8 @default.
- Q90830377 P2093 Q90830377-D20F83A1-5B97-4463-87EC-A57D2414A127 @default.
- Q90830377 P2093 Q90830377-E7AEE6AB-2208-4393-89FB-58A0BA00872D @default.
- Q90830377 P2093 Q90830377-EA855E7E-8B51-4122-A748-E483CDA751B7 @default.
- Q90830377 P31 Q90830377-63849FCA-7835-4C3B-8F31-DFB022C809CF @default.
- Q90830377 P356 Q90830377-3F6A809A-EC7E-42E2-ADCD-9F631D58472A @default.
- Q90830377 P50 Q90830377-7AA39237-2438-4B57-8344-392A2D100CA1 @default.
- Q90830377 P577 Q90830377-CB0881B8-EE83-4194-AADC-EE58C9B2A5E4 @default.
- Q90830377 P698 Q90830377-C764A21B-7B5C-4527-BA0B-4773B8DC9FBB @default.
- Q90830377 P921 Q90830377-0A668F1B-F63F-4770-A115-52B0CF3C3020 @default.
- Q90830377 P921 Q90830377-2A0CBD89-DD70-49C2-A1FF-7302B71D42A2 @default.
- Q90830377 P921 Q90830377-4F0DB415-60BE-47C4-871B-D7141318BD35 @default.
- Q90830377 P356 NNM-2020-0010 @default.
- Q90830377 P698 32238059 @default.
- Q90830377 P1433 Q15817508 @default.
- Q90830377 P1476 "Lignin-graft-PLGA drug-delivery system improves efficacy of MEK1/2 inhibitor in triple-negative breast cancer cell line" @default.
- Q90830377 P2093 "Adam T Melvin" @default.
- Q90830377 P2093 "Barbara L Knutson" @default.
- Q90830377 P2093 "Carlos E Astete" @default.
- Q90830377 P2093 "Cristina M Sabliov" @default.
- Q90830377 P2093 "Elizabeth C Martin" @default.
- Q90830377 P2093 "Mahsa Moradipour" @default.
- Q90830377 P2093 "Manibarathi Vaithiyanathan" @default.
- Q90830377 P2093 "Stephen E Rankin" @default.
- Q90830377 P31 Q13442814 @default.
- Q90830377 P356 "10.2217/NNM-2020-0010" @default.
- Q90830377 P50 Q90830375 @default.
- Q90830377 P577 "2020-04-02T00:00:00Z" @default.
- Q90830377 P698 "32238059" @default.
- Q90830377 P921 Q1392806 @default.
- Q90830377 P921 Q23058136 @default.
- Q90830377 P921 Q7843332 @default.